The gold standard critique of the original Pfizer trial

Senator Gerard Rennick

The gold standard critique of the original Pfizer trial is still that from the Canadian Covid alliance.
I’ve attached a longer version in comments but the summary is well worth watching as it highlights a number of key points albeit without audio.
Note: Not all animal testing was skipped as per comments on one slide. Results from animal testing varied and is still subject to debate.
There is also debate around testing for pregnant and breast feeding women. Both the DAEN reports and conversations with obstetricians, have indicated there have been adverse events in these categories. Some trials have indicated there are no safety issues but real world data, feedback from obstetricians and the post marketing surveillance data would indicate uncertainty as to absolute safety.
The key point to note is that none of the “in Vivo” trials actually used mRNA that expressed the spike protein but rather they used mRNA that expressed the benign enzyme luciferase.
(Fact checkers please take note of these qualifications and refer comments section.)

scroll down to more harm than good- https://www.canadiancovidcarealliance.org

Senator Gerard Rennick
Fact checkers: However, antibodies and T cells in monkeys declined quickly after 5 weeks after the second dose of BNT162b2 (V9) raising long term immunity concerns.
 The vaccine protected monkeys from infection when challenged 55 days after the 2nd vaccine dose based on viral RNA load and radiographic lung lesions. The vaccine dose in monkeys (100 μg) was higher than the proposed clinical dose of 30 μg. https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf There are no distribution and degradation data on the S antigen-encoding mRNA. A whole body imaging study with a surrogate, luciferase expressing mRNA indicate that the vaccine LNP formulation is expected to deliver the mRNA effectively in vivo, the mRNA and translated antigen protein are mainly localised at the injection site, distributed in liver and likely draining lymph nodes, and nearly completely degraded in 9 days.
 The limited studies showed slow elimination of ALC-0315 and retention in liver, and complete elimination of ALC-0159 in 14 days, with the latter eliminated in faeces most likely by biliary excretion. Both lipids are also eliminated by amide or ester hydrolysis.
 BNT162b2 (V9) was tolerated in rats without evidence of systemic toxicity. Rats administered BNT162b2 (V9) (3 IM doses once weekly at 30 μg/dose, ~200 times the clinical dose on a μg/kg basis) showed injection site inflammation, clinical pathology (increases in white blood cells, basophils, eosinophils, neutrophils, large unstained cells, fibrinogen, and acute phase proteins), and tissue pathology(hypercellularity of draining lymph nodes, spleen and bone marrow), consistent with immune stimulation and inflammation responses as well as minimal vacuolation of portal hepatocytes without evidence of liver injury. All effects were either partially or fully reversible after 3 weeks of recovery.

Dr. Wolf: The Continued Uncovering of the Pfizer Reports
https://rumble.com/v11gbf9-dr.-wolf-the-continued-uncovering-of-the-pfizer-reports.html?fbclid=IwAR0eNfGosZLhyoSIyqOgy0aeDZ4rwR3CEOgTAPIw7KO1bTw01PT6fLYG4vU

Source: https://www.facebook.com/watch/?v=499798491874072